FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082741854> ?p ?o ?g. }

• W2082741854 endingPage "3114" @default.
• W2082741854 startingPage "3107" @default.
• W2082741854 abstract "Abstract The initial analysis of the oral combination melphalan, prednisone, and thalidomide (MPT) in newly diagnosed patients with myeloma showed significantly higher response rate and longer progression-free survival (PFS) than did the standard melphalan and prednisone (MP) combination and suggested a survival advantage. In this updated analysis, efficacy and safety end points were updated. Patients were randomly assigned to receive oral MPT or MP alone. Updated analysis was by intention to treat and included PFS, overall survival (OS), and survival after progression. After a median follow-up of 38.1 months, the median PFS was 21.8 months for MPT and 14.5 months for MP (P = .004). The median OS was 45.0 months for MPT and 47.6 months for MP (P = .79). In different patient subgroups, MPT improved PFS irrespective of age, serum concentrations of β2-microglobulin, or high International Staging System. Thalidomide or bortezomib administration as salvage regimens significantly improved survival after progression in the MP group (P = .002) but not in the MPT group (P = .34). These data confirm activity of MPT for PFS but failed to show any survival advantage. New agents in the management of relapsed disease could explain this finding. The study is registered at www.clinicaltrials.gov as #NCT00232934." @default.
• W2082741854 created "2016-06-24" @default.
• W2082741854 creator A5013619928 @default.
• W2082741854 creator A5017728103 @default.
• W2082741854 creator A5018139001 @default.
• W2082741854 creator A5020113695 @default.
• W2082741854 creator A5026430732 @default.
• W2082741854 creator A5029477802 @default.
• W2082741854 creator A5034587847 @default.
• W2082741854 creator A5044869604 @default.
• W2082741854 creator A5046704362 @default.
• W2082741854 creator A5050615536 @default.
• W2082741854 creator A5051119817 @default.
• W2082741854 creator A5059967673 @default.
• W2082741854 creator A5066814162 @default.
• W2082741854 creator A5067110512 @default.
• W2082741854 creator A5071466957 @default.
• W2082741854 creator A5071926851 @default.
• W2082741854 creator A5072331165 @default.
• W2082741854 creator A5081653431 @default.
• W2082741854 creator A5083547233 @default.
• W2082741854 date "2008-10-15" @default.
• W2082741854 modified "2023-09-30" @default.
• W2082741854 title "Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial" @default.
• W2082741854 cites W1974876437 @default.
• W2082741854 cites W1978377409 @default.
• W2082741854 cites W2006382315 @default.
• W2082741854 cites W2033378587 @default.
• W2082741854 cites W2044436186 @default.
• W2082741854 cites W2107252423 @default.
• W2082741854 cites W2108235071 @default.
• W2082741854 cites W2110466835 @default.
• W2082741854 cites W2117172636 @default.
• W2082741854 cites W2120474651 @default.
• W2082741854 cites W2124560610 @default.
• W2082741854 cites W2141149919 @default.
• W2082741854 cites W2143756652 @default.
• W2082741854 cites W2156748957 @default.
• W2082741854 cites W2316160054 @default.
• W2082741854 cites W2470063969 @default.
• W2082741854 cites W2556749292 @default.
• W2082741854 cites W2589054503 @default.
• W2082741854 cites W4293241248 @default.
• W2082741854 doi "https://doi.org/10.1182/blood-2008-04-149427" @default.
• W2082741854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18505783" @default.
• W2082741854 hasPublicationYear "2008" @default.
• W2082741854 type Work @default.
• W2082741854 sameAs 2082741854 @default.
• W2082741854 citedByCount "331" @default.
• W2082741854 countsByYear W20827418542012 @default.
• W2082741854 countsByYear W20827418542013 @default.
• W2082741854 countsByYear W20827418542014 @default.
• W2082741854 countsByYear W20827418542015 @default.
• W2082741854 countsByYear W20827418542016 @default.
• W2082741854 countsByYear W20827418542017 @default.
• W2082741854 countsByYear W20827418542018 @default.
• W2082741854 countsByYear W20827418542019 @default.
• W2082741854 countsByYear W20827418542020 @default.
• W2082741854 countsByYear W20827418542021 @default.
• W2082741854 countsByYear W20827418542022 @default.
• W2082741854 countsByYear W20827418542023 @default.
• W2082741854 crossrefType "journal-article" @default.
• W2082741854 hasAuthorship W2082741854A5013619928 @default.
• W2082741854 hasAuthorship W2082741854A5017728103 @default.
• W2082741854 hasAuthorship W2082741854A5018139001 @default.
• W2082741854 hasAuthorship W2082741854A5020113695 @default.
• W2082741854 hasAuthorship W2082741854A5026430732 @default.
• W2082741854 hasAuthorship W2082741854A5029477802 @default.
• W2082741854 hasAuthorship W2082741854A5034587847 @default.
• W2082741854 hasAuthorship W2082741854A5044869604 @default.
• W2082741854 hasAuthorship W2082741854A5046704362 @default.
• W2082741854 hasAuthorship W2082741854A5050615536 @default.
• W2082741854 hasAuthorship W2082741854A5051119817 @default.
• W2082741854 hasAuthorship W2082741854A5059967673 @default.
• W2082741854 hasAuthorship W2082741854A5066814162 @default.
• W2082741854 hasAuthorship W2082741854A5067110512 @default.
• W2082741854 hasAuthorship W2082741854A5071466957 @default.
• W2082741854 hasAuthorship W2082741854A5071926851 @default.
• W2082741854 hasAuthorship W2082741854A5072331165 @default.
• W2082741854 hasAuthorship W2082741854A5081653431 @default.
• W2082741854 hasAuthorship W2082741854A5083547233 @default.
• W2082741854 hasBestOaLocation W20827418541 @default.
• W2082741854 hasConcept C126322002 @default.
• W2082741854 hasConcept C141071460 @default.
• W2082741854 hasConcept C143998085 @default.
• W2082741854 hasConcept C168563851 @default.
• W2082741854 hasConcept C2776063141 @default.
• W2082741854 hasConcept C2776364478 @default.
• W2082741854 hasConcept C2776694085 @default.
• W2082741854 hasConcept C2777478702 @default.
• W2082741854 hasConcept C2778684742 @default.
• W2082741854 hasConcept C2778720950 @default.
• W2082741854 hasConcept C2779609412 @default.
• W2082741854 hasConcept C2780739268 @default.
• W2082741854 hasConcept C71924100 @default.
• W2082741854 hasConcept C90924648 @default.
• W2082741854 hasConceptScore W2082741854C126322002 @default.
• W2082741854 hasConceptScore W2082741854C141071460 @default.

• next